#USA #Rancho Cucamonga #New World Medical #Ahmed Glaucoma Valve #KDB GLIDE

New World Medical's Latest Achievement: MDR Certification

In a significant development for the medical device industry, New World Medical recently announced that its Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE® have successfully obtained the Medical Device Regulation (MDR) certification within the European Union. This milestone represents a crucial transition from the previous Medical Device Directive (MDD) framework to the more stringent regulatory standards set by the MDR. As a result of this achievement, these devices will now be more accessible to surgeons and patients across Europe.

Raymond Kong, the Chief Commercial Officer of New World Medical, expressed pride in this accomplishment, highlighting the extensive organizational effort made to reach this point. “MDR certification reflects the tremendous effort and collaboration across our organization and enables us to continue supporting glaucoma surgeons in Europe with innovative solutions for their patients,” he stated. This certification not only validates the company's commitment to advancing glaucoma care but also signifies an essential step towards ensuring that patients have access to vision-preserving treatment options.

Future Directions for New World Medical

Looking forward, New World Medical aims to expand its product portfolio under MDR certification, with a notable priority on the Ahmed ClearPath® ST (ACP ST). This specific device, currently approved in over 20 countries globally, has emerged as a trusted choice for surgeons managing refractory glaucoma. Kong mentioned that European surgeons show increasing interest in the ACP ST, a next-generation small-tube glaucoma drainage device designed for enhanced surgical flexibility.

The MDR certification of ACP is crucial for New World Medical’s growth strategy in Europe, laying a strong regulatory foundation for future expansions, particularly concerning the Ahmed ClearPath portfolio. The company is actively collaborating with its notified body to secure MDR certification for ACP ST, aiming to make this advanced technology available to surgeons throughout Europe soon.

This accomplishment further fortifies New World Medical’s position in the global glaucoma landscape and resonates with the company's mission of enhancing and preserving vision through innovative solutions for patients. By achieving MDR certification, New World Medical not only ensures compliance with current regulations but also strengthens the trust of surgeons and patients alike in these vital medical devices.

About New World Medical

Founded by Dr. A. Mateen Ahmed, New World Medical has a clear mission to benefit humanity through innovative medical solutions. The company specializes in the development and manufacturing of surgical devices that offer vision-preserving treatments for glaucoma patients. Its product lineup includes some of the most recognized devices in the field, such as the Ahmed® Glaucoma Valve, Ahmed ClearPath®, KDB GLIDE®, the STREAMLINE® Surgical System, and the VIA360™ Surgical System.

The culmination of New World Medical's efforts reflects a dedicated commitment to improving glaucoma care worldwide and ensuring that surgeons have access to the best possible tools to help their patients. For more information about New World Medical and its innovative devices, visit New World Medical's official website.